Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with all-trans retinoic acid and arsenic compound-based combined therapies.
about
Research on the effect of ginseng polysaccharide on apoptosis and cell cycle of human leukemia cell line K562 and its molecular mechanismsVorinostat enhances chemosensitivity to arsenic trioxide in K562 cell line.Molecular and hematologic relapses in adult patients with acute promyelocytic leukemia: a cohort study.Contemporary treatment of APLChemosensitivity enhancement toward arsenic trioxide by inhibition of histone deacetylase in NB4 cell line.AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesis.
P2860
Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with all-trans retinoic acid and arsenic compound-based combined therapies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment outcomes in relapsed ...... ound-based combined therapies.
@en
Treatment outcomes in relapsed ...... ound-based combined therapies.
@nl
type
label
Treatment outcomes in relapsed ...... ound-based combined therapies.
@en
Treatment outcomes in relapsed ...... ound-based combined therapies.
@nl
prefLabel
Treatment outcomes in relapsed ...... ound-based combined therapies.
@en
Treatment outcomes in relapsed ...... ound-based combined therapies.
@nl
P2093
P2860
P356
P1433
P1476
Treatment outcomes in relapsed ...... ound-based combined therapies.
@en
P2093
P2860
P304
P356
10.3892/OL.2013.1643
P577
2013-10-25T00:00:00Z